Li Zhong-Min, Kannan Kurunthachalam
Department of Pediatrics, New York University Grossman School of Medicine, New York, NY 10016, USA.
Department of Environmental Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA.
Toxics. 2022 Nov 12;10(11):687. doi: 10.3390/toxics10110687.
This paper describes a methodology for simultaneous determination of 19 steroid hormones, viz. estrone, estradiol, estriol, testosterone, 5α-dihydrotestosterone, androstenedione, androstenediol, dehydroepiandrosterone, progesterone, pregnenolone, 17α-OH-progesterone, 17α-OH-pregnenolone, cortisone, cortisol, 11-deoxycortisol, 11-deoxycorticosterone, 11-dehydrocorticosterone, aldosterone, and corticosterone, in 500-µL of urine or serum/plasma. The method was optimized using isotopically labeled internal standards and liquid-liquid extraction followed by detection using liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-MS/MS). Dansylation of estrogens significantly improved their sensitivities (~11- to 23-fold) and chromatographic separation. The respective limit of detection (LOD) and limit of quantification (LOQ) of all analytes were 0.04−0.28 and 0.14−0.92 ng/mL in human urine, and 0.11−0.35 and 0.38−1.18 ng/mL in human serum/plasma. Recoveries of all analytes (except for progesterone) fortified at 10, 20, and 200 ng/mL in urine and serum were 80−120%, with standard deviations ranging from 0 to 17.3%. Repeated analysis of similarly fortified urine and serum samples yielded intra-day and inter-day variations of 0−21.7% and 0.16−11.5%, respectively. All analytes except cortisone exhibited weak matrix effects in urine and serum (−13.9−18.2%). The method was further validated through the analysis of the National Institute of Standards and Technology (NIST) plasma Standard Reference Material (SRM1950) with certified concentrations for cortisol, progesterone, and testosterone (coefficient of variation: 3−11%). The developed method was applied in the analysis of urine samples from 20 volunteers, which revealed the occurrence of 16 analytes with detection frequencies (DFs) > 80%. Furthermore, 15 analytes were found in plasma SRM1950, indicating the feasibility of our method in the analysis of steroid hormones in urine and serum/plasma. This method will facilitate analysis of steroid hormones in population-based biomonitoring studies.
本文介绍了一种同时测定500微升尿液或血清/血浆中19种甾体激素的方法,这些激素分别是雌酮、雌二醇、雌三醇、睾酮、5α-二氢睾酮、雄烯二酮、雄烯二醇、脱氢表雄酮、孕酮、孕烯醇酮、17α-羟基孕酮、17α-羟基孕烯醇酮、可的松、皮质醇、11-脱氧皮质醇、11-脱氧皮质酮、11-脱氢皮质酮、醛固酮和皮质酮。该方法使用同位素标记的内标进行优化,采用液液萃取,随后使用液相色谱-电喷雾电离-串联质谱(LC-MS/MS)进行检测。雌激素的丹磺酰化显著提高了它们的灵敏度(约11至23倍)以及色谱分离效果。所有分析物在人尿中的检测限(LOD)和定量限(LOQ)分别为0.04−0.28和0.14−0.92纳克/毫升,在人血清/血浆中的检测限和定量限分别为0.11−0.35和0.38−1.18纳克/毫升。在尿液和血清中添加浓度为10、20和200纳克/毫升的所有分析物(孕酮除外)的回收率为80−120%,标准偏差范围为0至17.3%。对同样添加的尿液和血清样本进行重复分析,日内和日间变化分别为0−21.7%和0.16−11.5%。除可的松外,所有分析物在尿液和血清中均表现出较弱的基质效应(-13.9−18.2%)。通过分析美国国家标准与技术研究院(NIST)的血浆标准参考物质(SRM1950)中已认证的皮质醇、孕酮和睾酮浓度,进一步验证了该方法(变异系数:3−11%)。所开发的方法应用于20名志愿者的尿液样本分析,结果显示有16种分析物的检出频率(DFs)>80%。此外,在血浆SRM1950中发现了15种分析物,表明我们的方法在尿液和血清/血浆甾体激素分析中具有可行性。该方法将有助于在基于人群的生物监测研究中分析甾体激素。